5GT-90364-16048
3 vaccinations
4 coded responses
32 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 553 / MN
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-13
- 2021-01-14
- 2021-01-22
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
-
2021-02-12
Survey response — day 14, dose 2MedDRA: Antibiotic therapy, Sinusitis — Feeling: Fair · Be unable to workFree text: Sinus infection- started on antibioticsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-25
-
2021-03-04
Survey response — day 35, dose 2MedDRA: Back pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Unbearable upper back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-04-29
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Sinus infectionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-28
Dose 3 — Pfizer-BioNTech
- 2021-11-28
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-12-16
- 2022-01-02
- 2022-01-10
- 2022-03-01
-
2022-05-29
Survey response — 6 months, dose 3MedDRA: Hip arthroplasty — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Hip replacementMedDRA releases: 2024-11 · check-in free text available
-
2022-05-29
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-06-01
- 2022-11-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-11-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-29 | Unsuccessful |
Free text
Release 4 — day 14, dose 2
Symptoms: Sinus infection- started on antibiotics
Release 5 — day 35, dose 2
Symptoms: Unbearable upper back pain
Release 9 — 6 months, dose 2
Symptoms: Sinus infection
Release 11 — 6 months, dose 3
Symptoms: Hip replacement
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Antibiotic therapy | ✓ | ✓ | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Hip arthroplasty | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release